nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CACNA1G—type 1 diabetes mellitus	0.602	0.733	CbGaD
Pimozide—CHRM2—type 1 diabetes mellitus	0.219	0.267	CbGaD
Pimozide—HTR2A—arteriole—type 1 diabetes mellitus	0.00379	0.0907	CbGeAlD
Pimozide—CALM1—autonomic nervous system—type 1 diabetes mellitus	0.00267	0.0638	CbGeAlD
Pimozide—OPRM1—nerve—type 1 diabetes mellitus	0.00208	0.0497	CbGeAlD
Pimozide—Flunarizine—CACNA1G—type 1 diabetes mellitus	0.00198	0.723	CrCbGaD
Pimozide—CALM2—peripheral nervous system—type 1 diabetes mellitus	0.00193	0.0462	CbGeAlD
Pimozide—CALM1—peripheral nervous system—type 1 diabetes mellitus	0.00192	0.046	CbGeAlD
Pimozide—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00162	0.0388	CbGeAlD
Pimozide—CALM2—nerve—type 1 diabetes mellitus	0.00151	0.036	CbGeAlD
Pimozide—CALM1—nerve—type 1 diabetes mellitus	0.0015	0.0359	CbGeAlD
Pimozide—DRD2—nerve—type 1 diabetes mellitus	0.00138	0.0331	CbGeAlD
Pimozide—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00117	0.028	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.00106	0.0254	CbGeAlD
Pimozide—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.000955	0.0503	CcSEcCtD
Pimozide—CALM3—islet of Langerhans—type 1 diabetes mellitus	0.000929	0.0222	CbGeAlD
Pimozide—HTR2A—nerve—type 1 diabetes mellitus	0.000913	0.0219	CbGeAlD
Pimozide—CALM3—retina—type 1 diabetes mellitus	0.000794	0.019	CbGeAlD
Pimozide—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.000769	0.0405	CcSEcCtD
Pimozide—Fluspirilene—ADRB1—type 1 diabetes mellitus	0.00076	0.277	CrCbGaD
Pimozide—CALM3—nephron tubule—type 1 diabetes mellitus	0.000748	0.0179	CbGeAlD
Pimozide—CALM2—islet of Langerhans—type 1 diabetes mellitus	0.00073	0.0175	CbGeAlD
Pimozide—CALM1—islet of Langerhans—type 1 diabetes mellitus	0.000726	0.0174	CbGeAlD
Pimozide—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.000708	0.0373	CcSEcCtD
Pimozide—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000662	0.0158	CbGeAlD
Pimozide—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.000661	0.0158	CbGeAlD
Pimozide—CALM3—pancreas—type 1 diabetes mellitus	0.000653	0.0156	CbGeAlD
Pimozide—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.000636	0.0335	CcSEcCtD
Pimozide—CALM2—retina—type 1 diabetes mellitus	0.000624	0.0149	CbGeAlD
Pimozide—CALM1—retina—type 1 diabetes mellitus	0.000621	0.0149	CbGeAlD
Pimozide—CALM2—nephron tubule—type 1 diabetes mellitus	0.000588	0.0141	CbGeAlD
Pimozide—CALM1—nephron tubule—type 1 diabetes mellitus	0.000585	0.014	CbGeAlD
Pimozide—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000577	0.0304	CcSEcCtD
Pimozide—DRD2—retina—type 1 diabetes mellitus	0.000574	0.0137	CbGeAlD
Pimozide—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.000546	0.0131	CbGeAlD
Pimozide—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000537	0.0128	CbGeAlD
Pimozide—CALM2—cardiovascular system—type 1 diabetes mellitus	0.000528	0.0126	CbGeAlD
Pimozide—CALM1—cardiovascular system—type 1 diabetes mellitus	0.000525	0.0126	CbGeAlD
Pimozide—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000525	0.0277	CcSEcCtD
Pimozide—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000519	0.0274	CcSEcCtD
Pimozide—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.000517	0.0273	CcSEcCtD
Pimozide—CALM2—kidney—type 1 diabetes mellitus	0.000516	0.0124	CbGeAlD
Pimozide—CALM1—kidney—type 1 diabetes mellitus	0.000514	0.0123	CbGeAlD
Pimozide—CALM2—pancreas—type 1 diabetes mellitus	0.000513	0.0123	CbGeAlD
Pimozide—CALM1—pancreas—type 1 diabetes mellitus	0.000511	0.0122	CbGeAlD
Pimozide—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000497	0.0262	CcSEcCtD
Pimozide—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000492	0.0259	CcSEcCtD
Pimozide—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000478	0.0114	CbGeAlD
Pimozide—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000476	0.0251	CcSEcCtD
Pimozide—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000472	0.0249	CcSEcCtD
Pimozide—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000457	0.0241	CcSEcCtD
Pimozide—Weight increased—Ramipril—type 1 diabetes mellitus	0.000452	0.0238	CcSEcCtD
Pimozide—CALM2—lymphoid tissue—type 1 diabetes mellitus	0.000443	0.0106	CbGeAlD
Pimozide—CALM1—lymphoid tissue—type 1 diabetes mellitus	0.000441	0.0106	CbGeAlD
Pimozide—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.000439	0.0105	CbGeAlD
Pimozide—Sweating—Ramipril—type 1 diabetes mellitus	0.000424	0.0224	CcSEcCtD
Pimozide—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000413	0.0218	CcSEcCtD
Pimozide—CYP2E1—nephron tubule—type 1 diabetes mellitus	0.00041	0.00981	CbGeAlD
Pimozide—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000391	0.0206	CcSEcCtD
Pimozide—CYP3A5—kidney—type 1 diabetes mellitus	0.000386	0.00924	CbGeAlD
Pimozide—CYP3A5—pancreas—type 1 diabetes mellitus	0.000384	0.00918	CbGeAlD
Pimozide—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000383	0.0202	CcSEcCtD
Pimozide—HTR2A—retina—type 1 diabetes mellitus	0.000378	0.00905	CbGeAlD
Pimozide—CYP2E1—cardiovascular system—type 1 diabetes mellitus	0.000368	0.00881	CbGeAlD
Pimozide—CYP2E1—kidney—type 1 diabetes mellitus	0.00036	0.00862	CbGeAlD
Pimozide—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000348	0.0184	CcSEcCtD
Pimozide—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000333	0.0175	CcSEcCtD
Pimozide—Tremor—Ramipril—type 1 diabetes mellitus	0.000324	0.0171	CcSEcCtD
Pimozide—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00032	0.00765	CbGeAlD
Pimozide—Agitation—Ramipril—type 1 diabetes mellitus	0.000318	0.0168	CcSEcCtD
Pimozide—HTR2A—kidney—type 1 diabetes mellitus	0.000313	0.00749	CbGeAlD
Pimozide—Syncope—Ramipril—type 1 diabetes mellitus	0.00031	0.0164	CcSEcCtD
Pimozide—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00031	0.0163	CcSEcCtD
Pimozide—CYP2E1—lymphoid tissue—type 1 diabetes mellitus	0.000309	0.0074	CbGeAlD
Pimozide—Palpitations—Ramipril—type 1 diabetes mellitus	0.000306	0.0161	CcSEcCtD
Pimozide—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000304	0.016	CcSEcCtD
Pimozide—Convulsion—Ramipril—type 1 diabetes mellitus	0.0003	0.0158	CcSEcCtD
Pimozide—Myalgia—Ramipril—type 1 diabetes mellitus	0.000295	0.0155	CcSEcCtD
Pimozide—Chest pain—Ramipril—type 1 diabetes mellitus	0.000295	0.0155	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000293	0.0154	CcSEcCtD
Pimozide—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00029	0.00694	CbGeAlD
Pimozide—CYP3A4—kidney—type 1 diabetes mellitus	0.00029	0.00693	CbGeAlD
Pimozide—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000288	0.0152	CcSEcCtD
Pimozide—CYP2D6—kidney—type 1 diabetes mellitus	0.000285	0.00682	CbGeAlD
Pimozide—Shock—Ramipril—type 1 diabetes mellitus	0.000278	0.0146	CcSEcCtD
Pimozide—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000277	0.0146	CcSEcCtD
Pimozide—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000276	0.0145	CcSEcCtD
Pimozide—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000274	0.0145	CcSEcCtD
Pimozide—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000273	0.0144	CcSEcCtD
Pimozide—Anorexia—Ramipril—type 1 diabetes mellitus	0.000269	0.0142	CcSEcCtD
Pimozide—Hypotension—Ramipril—type 1 diabetes mellitus	0.000264	0.0139	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000257	0.0136	CcSEcCtD
Pimozide—Insomnia—Ramipril—type 1 diabetes mellitus	0.000255	0.0135	CcSEcCtD
Pimozide—Somnolence—Ramipril—type 1 diabetes mellitus	0.000251	0.0132	CcSEcCtD
Pimozide—ABCB1—retina—type 1 diabetes mellitus	0.000248	0.00593	CbGeAlD
Pimozide—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000245	0.0129	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000244	0.0128	CcSEcCtD
Pimozide—Constipation—Ramipril—type 1 diabetes mellitus	0.000241	0.0127	CcSEcCtD
Pimozide—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000233	0.00558	CbGeAlD
Pimozide—Urticaria—Ramipril—type 1 diabetes mellitus	0.000224	0.0118	CcSEcCtD
Pimozide—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00021	0.00502	CbGeAlD
Pimozide—ABCB1—kidney—type 1 diabetes mellitus	0.000205	0.00491	CbGeAlD
Pimozide—ABCB1—pancreas—type 1 diabetes mellitus	0.000204	0.00488	CbGeAlD
Pimozide—Asthenia—Ramipril—type 1 diabetes mellitus	0.000203	0.0107	CcSEcCtD
Pimozide—Pruritus—Ramipril—type 1 diabetes mellitus	0.0002	0.0105	CcSEcCtD
Pimozide—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000193	0.0102	CcSEcCtD
Pimozide—Dizziness—Ramipril—type 1 diabetes mellitus	0.000187	0.00984	CcSEcCtD
Pimozide—Vomiting—Ramipril—type 1 diabetes mellitus	0.00018	0.00946	CcSEcCtD
Pimozide—Rash—Ramipril—type 1 diabetes mellitus	0.000178	0.00938	CcSEcCtD
Pimozide—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000178	0.00937	CcSEcCtD
Pimozide—Headache—Ramipril—type 1 diabetes mellitus	0.000177	0.00932	CcSEcCtD
Pimozide—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000176	0.00422	CbGeAlD
Pimozide—Nausea—Ramipril—type 1 diabetes mellitus	0.000168	0.00884	CcSEcCtD
Pimozide—CALM3—Innate Immune System—EGFR—type 1 diabetes mellitus	6.34e-06	5.5e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NOS2—type 1 diabetes mellitus	6.33e-06	5.49e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NOS2—type 1 diabetes mellitus	6.33e-06	5.49e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.33e-06	5.49e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.3e-06	5.46e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.26e-06	5.42e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.25e-06	5.42e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.2e-06	5.37e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.15e-06	5.33e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.15e-06	5.33e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CD80—type 1 diabetes mellitus	6.14e-06	5.32e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CD80—type 1 diabetes mellitus	6.14e-06	5.32e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—EGFR—type 1 diabetes mellitus	6.14e-06	5.32e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—EGFR—type 1 diabetes mellitus	6.14e-06	5.32e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.12e-06	5.31e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.12e-06	5.31e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	6.12e-06	5.31e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CD86—type 1 diabetes mellitus	6.09e-06	5.28e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—EGFR—type 1 diabetes mellitus	6.09e-06	5.28e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.06e-06	5.26e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	6e-06	5.21e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—INS—type 1 diabetes mellitus	6e-06	5.2e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.98e-06	5.18e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.97e-06	5.17e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.95e-06	5.16e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.94e-06	5.15e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CD86—type 1 diabetes mellitus	5.9e-06	5.11e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CD86—type 1 diabetes mellitus	5.9e-06	5.11e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.89e-06	5.11e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.89e-06	5.11e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.89e-06	5.11e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.89e-06	5.11e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	5.88e-06	5.1e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	5.88e-06	5.09e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.86e-06	5.08e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.85e-06	5.07e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—TYK2—type 1 diabetes mellitus	5.8e-06	5.03e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—INS—type 1 diabetes mellitus	5.8e-06	5.03e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—INS—type 1 diabetes mellitus	5.8e-06	5.03e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.78e-06	5.01e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.74e-06	4.97e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.7e-06	4.94e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.67e-06	4.91e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.64e-06	4.89e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—TYK2—type 1 diabetes mellitus	5.62e-06	4.87e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—TYK2—type 1 diabetes mellitus	5.62e-06	4.87e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.59e-06	4.85e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.59e-06	4.85e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.5e-06	4.76e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.44e-06	4.72e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNG—type 1 diabetes mellitus	5.44e-06	4.71e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	5.41e-06	4.69e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	5.41e-06	4.69e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.4e-06	4.69e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	5.37e-06	4.65e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TYK2—type 1 diabetes mellitus	5.36e-06	4.65e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.36e-06	4.64e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.34e-06	4.63e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	5.33e-06	4.62e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.33e-06	4.62e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.32e-06	4.61e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.32e-06	4.61e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.29e-06	4.58e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—NOS3—type 1 diabetes mellitus	5.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNG—type 1 diabetes mellitus	5.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNG—type 1 diabetes mellitus	5.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD4—type 1 diabetes mellitus	5.25e-06	4.55e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	5.24e-06	4.54e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.23e-06	4.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.23e-06	4.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.23e-06	4.53e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TYK2—type 1 diabetes mellitus	5.18e-06	4.49e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TYK2—type 1 diabetes mellitus	5.18e-06	4.49e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.15e-06	4.47e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.15e-06	4.47e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	5.14e-06	4.46e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.14e-06	4.45e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.11e-06	4.43e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.11e-06	4.43e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NOS3—type 1 diabetes mellitus	5.09e-06	4.41e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NOS3—type 1 diabetes mellitus	5.09e-06	4.41e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD4—type 1 diabetes mellitus	5.08e-06	4.4e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD4—type 1 diabetes mellitus	5.08e-06	4.4e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	5.06e-06	4.39e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	5.06e-06	4.38e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.05e-06	4.38e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	5.05e-06	4.38e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	5.05e-06	4.37e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.04e-06	4.37e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—INS—type 1 diabetes mellitus	5.02e-06	4.36e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.02e-06	4.35e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.02e-06	4.35e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	5e-06	4.34e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	5e-06	4.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.97e-06	4.31e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.97e-06	4.31e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	4.97e-06	4.31e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.95e-06	4.29e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.95e-06	4.29e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.89e-06	4.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.88e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—type 1 diabetes mellitus	4.87e-06	4.23e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.87e-06	4.22e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.86e-06	4.21e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—INS—type 1 diabetes mellitus	4.86e-06	4.21e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—INS—type 1 diabetes mellitus	4.86e-06	4.21e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—type 1 diabetes mellitus	4.85e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CD4—type 1 diabetes mellitus	4.85e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2—type 1 diabetes mellitus	4.83e-06	4.19e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.81e-06	4.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.78e-06	4.15e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—type 1 diabetes mellitus	4.72e-06	4.09e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—type 1 diabetes mellitus	4.72e-06	4.09e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—type 1 diabetes mellitus	4.69e-06	4.07e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—type 1 diabetes mellitus	4.69e-06	4.07e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CD4—type 1 diabetes mellitus	4.69e-06	4.06e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CD4—type 1 diabetes mellitus	4.69e-06	4.06e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2—type 1 diabetes mellitus	4.67e-06	4.05e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2—type 1 diabetes mellitus	4.67e-06	4.05e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	4.64e-06	4.02e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	4.63e-06	4.01e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ALB—type 1 diabetes mellitus	4.61e-06	3.99e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.59e-06	3.98e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.58e-06	3.97e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.57e-06	3.96e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.52e-06	3.92e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.51e-06	3.91e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.51e-06	3.91e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.5e-06	3.9e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ALB—type 1 diabetes mellitus	4.46e-06	3.86e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ALB—type 1 diabetes mellitus	4.46e-06	3.86e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CD80—type 1 diabetes mellitus	4.45e-06	3.85e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.44e-06	3.85e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.44e-06	3.85e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	4.43e-06	3.84e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.43e-06	3.84e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	4.42e-06	3.84e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—NOS3—type 1 diabetes mellitus	4.41e-06	3.82e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.36e-06	3.78e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.36e-06	3.78e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.35e-06	3.77e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.33e-06	3.76e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CD80—type 1 diabetes mellitus	4.3e-06	3.73e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.3e-06	3.73e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—NOS3—type 1 diabetes mellitus	4.26e-06	3.69e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—NOS3—type 1 diabetes mellitus	4.26e-06	3.69e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.25e-06	3.68e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.2e-06	3.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—INS—type 1 diabetes mellitus	4.2e-06	3.64e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.17e-06	3.62e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—STAT3—type 1 diabetes mellitus	4.06e-06	3.52e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—INS—type 1 diabetes mellitus	4.06e-06	3.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—INS—type 1 diabetes mellitus	4.06e-06	3.52e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.06e-06	3.52e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.04e-06	3.5e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—type 1 diabetes mellitus	3.93e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—type 1 diabetes mellitus	3.93e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.93e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.93e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.91e-06	3.39e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.91e-06	3.39e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.9e-06	3.38e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.86e-06	3.34e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.83e-06	3.32e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.82e-06	3.31e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.82e-06	3.31e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.81e-06	3.3e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.8e-06	3.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.77e-06	3.27e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.76e-06	3.26e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.76e-06	3.26e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.75e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.75e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—type 1 diabetes mellitus	3.75e-06	3.25e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.74e-06	3.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.74e-06	3.24e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.7e-06	3.21e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—type 1 diabetes mellitus	3.69e-06	3.2e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.69e-06	3.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.68e-06	3.19e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.68e-06	3.19e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.66e-06	3.18e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.63e-06	3.15e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.63e-06	3.15e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—type 1 diabetes mellitus	3.63e-06	3.15e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—type 1 diabetes mellitus	3.63e-06	3.15e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.59e-06	3.11e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	3.58e-06	3.1e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—type 1 diabetes mellitus	3.57e-06	3.1e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—type 1 diabetes mellitus	3.57e-06	3.1e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.56e-06	3.09e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.56e-06	3.09e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.53e-06	3.06e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.51e-06	3.04e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.49e-06	3.03e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	3.46e-06	3e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.42e-06	2.97e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—type 1 diabetes mellitus	3.41e-06	2.96e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.34e-06	2.89e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.33e-06	2.89e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—type 1 diabetes mellitus	3.3e-06	2.86e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—type 1 diabetes mellitus	3.3e-06	2.86e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.29e-06	2.85e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.22e-06	2.79e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.17e-06	2.74e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.16e-06	2.74e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.15e-06	2.73e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.13e-06	2.71e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—type 1 diabetes mellitus	3.12e-06	2.71e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.11e-06	2.69e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.11e-06	2.69e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.04e-06	2.63e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.03e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.03e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.02e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.02e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.01e-06	2.61e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.01e-06	2.61e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.97e-06	2.57e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.94e-06	2.55e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.92e-06	2.53e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.88e-06	2.49e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.87e-06	2.49e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—type 1 diabetes mellitus	2.84e-06	2.46e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.82e-06	2.45e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.79e-06	2.42e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—type 1 diabetes mellitus	2.75e-06	2.38e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—type 1 diabetes mellitus	2.75e-06	2.38e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.67e-06	2.31e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.63e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—type 1 diabetes mellitus	2.62e-06	2.27e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.56e-06	2.22e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.54e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.54e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—type 1 diabetes mellitus	2.54e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—type 1 diabetes mellitus	2.54e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.39e-06	2.07e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.35e-06	2.03e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.31e-06	2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.31e-06	2e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.25e-06	1.95e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.21e-06	1.92e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.21e-06	1.91e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.17e-06	1.88e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.15e-06	1.86e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.06e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.84e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.78e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.78e-06	1.54e-05	CbGpPWpGaD
